NO996372D0 - Fast farmasoeytisk preparat inneholdende benzofuanderivater - Google Patents

Fast farmasoeytisk preparat inneholdende benzofuanderivater

Info

Publication number
NO996372D0
NO996372D0 NO996372A NO996372A NO996372D0 NO 996372 D0 NO996372 D0 NO 996372D0 NO 996372 A NO996372 A NO 996372A NO 996372 A NO996372 A NO 996372A NO 996372 D0 NO996372 D0 NO 996372D0
Authority
NO
Norway
Prior art keywords
benzofuan
derivatives
pharmaceutical preparation
preparation containing
solid pharmaceutical
Prior art date
Application number
NO996372A
Other languages
English (en)
Other versions
NO326758B1 (no
NO996372L (no
Inventor
Bernard Abramovici
Jean-Claude Gautier
Jean-Claude Gromenil
Jean-Marie Marrier
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9508303&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO996372(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO996372D0 publication Critical patent/NO996372D0/no
Publication of NO996372L publication Critical patent/NO996372L/no
Publication of NO326758B1 publication Critical patent/NO326758B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19996372A 1997-06-23 1999-12-21 Fast farmasoytisk preparat inneholdende benzofuanderivater NO326758B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9707795A FR2764800B1 (fr) 1997-06-23 1997-06-23 Composition pharmaceutique solide contenant des derives de benzofuranne
PCT/FR1998/001285 WO1998058643A1 (fr) 1997-06-23 1998-06-19 Composition pharmaceutique solide contenant des derives de benzofuranne

Publications (3)

Publication Number Publication Date
NO996372D0 true NO996372D0 (no) 1999-12-21
NO996372L NO996372L (no) 2000-02-23
NO326758B1 NO326758B1 (no) 2009-02-09

Family

ID=9508303

Family Applications (2)

Application Number Title Priority Date Filing Date
NO19996372A NO326758B1 (no) 1997-06-23 1999-12-21 Fast farmasoytisk preparat inneholdende benzofuanderivater
NO2010009C NO2010009I2 (no) 1997-06-23 2010-05-06 Dronedaron (rlNN) produktet av stoffet MULTAQ som omfattes i a. av basispatentets krav 1, eksplisittkrav 2 og hydroklorid (HCI) salt i krav 4. Se ogs å The Merck Index

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO2010009C NO2010009I2 (no) 1997-06-23 2010-05-06 Dronedaron (rlNN) produktet av stoffet MULTAQ som omfattes i a. av basispatentets krav 1, eksplisittkrav 2 og hydroklorid (HCI) salt i krav 4. Se ogs å The Merck Index

Country Status (43)

Country Link
US (5) US7323493B1 (no)
EP (1) EP1007030B3 (no)
JP (1) JP4577732B2 (no)
KR (1) KR100542089B1 (no)
CN (1) CN1091593C (no)
AR (1) AR013117A1 (no)
AT (1) ATE264677T1 (no)
AU (1) AU728287B2 (no)
BR (1) BR9810320A (no)
CA (1) CA2294812C (no)
CO (1) CO5011091A1 (no)
CY (1) CY2010002I1 (no)
CZ (1) CZ295191B6 (no)
DE (2) DE122010000029I1 (no)
DK (1) DK1007030T6 (no)
DZ (1) DZ2526A1 (no)
EE (1) EE03852B1 (no)
EG (1) EG23762A (no)
ES (1) ES2221178T7 (no)
FR (2) FR2764800B1 (no)
GT (1) GT199800101A (no)
HK (1) HK1028352A1 (no)
HR (1) HRP980355B1 (no)
HU (1) HU229266B1 (no)
ID (1) ID23872A (no)
IL (1) IL133605A0 (no)
IS (1) IS2340B (no)
LU (1) LU91673I2 (no)
MY (1) MY122124A (no)
NO (2) NO326758B1 (no)
NZ (1) NZ502464A (no)
PL (1) PL190127B1 (no)
PT (1) PT1007030E (no)
RU (1) RU2191578C2 (no)
SA (1) SA98190327B1 (no)
SI (1) SI1007030T1 (no)
SK (1) SK284972B6 (no)
TR (1) TR199903236T2 (no)
TW (1) TW548108B (no)
UA (1) UA56243C2 (no)
UY (1) UY25062A1 (no)
WO (1) WO1998058643A1 (no)
ZA (1) ZA985456B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2764800B1 (fr) * 1997-06-23 1999-09-10 Sanofi Sa Composition pharmaceutique solide contenant des derives de benzofuranne
DE19913692A1 (de) * 1999-03-25 2000-09-28 Basf Ag Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen
GB0719180D0 (en) 2007-10-02 2007-11-14 Cambrex Karlskoga Ab New process
FR2930149B1 (fr) * 2008-04-17 2011-02-18 Sanofi Aventis Association de dronedarone avec au moins un diuretique, son application en therapeutique
KR20100135909A (ko) * 2008-04-17 2010-12-27 사노피-아벤티스 심혈관성 입원 또는 사망을 예방하는데 사용하기 위한 약제의 제조에 있어서의 드로네다론의 용도
EP2116239A1 (en) * 2008-04-29 2009-11-11 Sanofi-Aventis Method for managing the risks associated with an increase in serum creatinine during dronedarone treatment
MX344677B (es) * 2009-10-09 2017-01-04 Mueller Int Llc * Dispositivo sellador simplificado de baja fuerza de inserción capaz de auto-restringir y desviar junta.
CN102078307B (zh) * 2009-12-01 2012-11-07 天津市汉康医药生物技术有限公司 一种盐酸决奈达隆固体分散体的药物组合物及其制备方法
TWI508726B (zh) 2009-12-21 2015-11-21 Gilead Sciences Inc 治療心房纖維性顫動之方法
WO2011135581A2 (en) 2010-04-28 2011-11-03 Cadila Healthcare Limited Pharmaceutical compositions of dronedarone
WO2011135582A2 (en) 2010-04-28 2011-11-03 Cadila Healthcare Limited Pharmaceutical compositions of dronedarone
US8602215B2 (en) 2010-06-30 2013-12-10 Sanofi Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation
CN102342907A (zh) * 2010-07-30 2012-02-08 江苏恒瑞医药股份有限公司 决奈达隆固体分散体及其制备方法
WO2012023024A2 (en) 2010-08-17 2012-02-23 Lupin Limited Controlled release formulations of dronedarone
FR2967067A1 (fr) * 2010-11-10 2012-05-11 Sanofi Aventis Composition pharmaceutique et forme galenique a base de dronedarone et son procede de preparation
KR20120094557A (ko) * 2011-02-01 2012-08-27 동아제약주식회사 피에이치 비의존적 용출양상을 갖는 부정맥치료제 제제
GB2491380A (en) * 2011-06-01 2012-12-05 Jagotec Ag Pharmaceutical composition comprising dronedarone hydrochloride that exhibits a reduced food effect
FR2977495B1 (fr) * 2011-07-07 2014-03-07 Sanofi Sa Composition pharmaceutique et forme galenique solide a haute teneur en dronedarone et son procede de preparation
WO2013024411A1 (en) 2011-08-12 2013-02-21 Lupin Limited Co-milled formulation of dronedarone
CN102349889B (zh) * 2011-11-01 2013-08-28 江苏先声药物研究有限公司 一种含有决奈达隆的组合物
CN103126994B (zh) * 2011-12-05 2017-03-29 北京虹湾医药技术有限公司 含决奈达隆的固体药物组合物
EP2817001A1 (en) 2012-02-20 2014-12-31 Lupin Limited Bilayer tablet of dronedarone
CN103054820B (zh) * 2012-08-22 2016-07-13 石药集团中奇制药技术（石家庄）有限公司 一种盐酸决奈达隆药物组合物及其制备方法
CN104771376B (zh) * 2014-01-15 2021-01-29 山东新时代药业有限公司 一种盐酸决奈达隆片剂及其制备方法
WO2016120299A1 (en) 2015-01-28 2016-08-04 Sanovel Ilac Sanayi Ve Ticaret A.S. Orally disintegrating formulations of dronedarone
TR201501970A2 (en) 2015-02-19 2016-09-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Pharmaceutical combinations of dronedarone.
TR201502223A2 (tr) 2015-02-25 2016-09-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Dronedaron ve dabigatranın farmasötik kombinasyonları.
TR201503136A2 (tr) 2015-03-16 2016-09-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Dronedaron ve esansiyel yağ asitlerinin farmasötik kompozisyonları.
RU2624857C1 (ru) * 2016-01-26 2017-07-07 федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургская государственная химико-фармацевтическая академия" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СПХФА Минздрава России) Фармацевтическая композиция с противогрибковой активностью и способ ее получения
CN108042489A (zh) * 2017-12-19 2018-05-18 佛山市弘泰药物研发有限公司 一种盐酸决奈达隆自微乳制剂及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3248401A (en) 1966-04-26 Diethylaminoe hoxybenzoyl benzofurans
US4777048A (en) * 1983-07-07 1988-10-11 American Home Products Corporation Pharmaceutical composition containing a liquid lubricant
GB8630273D0 (en) * 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems
US4851554A (en) 1987-04-06 1989-07-25 University Of Tennessee Research Corporation Certain 3-substituted 2-alkyl benzofuran derivatives
US4806663A (en) 1987-04-06 1989-02-21 The University Of Tennessee Research Corporation Certain 3-substituted 2-alkyl benzofuran derivatives
US4831054A (en) 1988-04-18 1989-05-16 Taro Pharmaceuticals, Ltd. 2-Alkyl-3-benzoylbenzofurans useful for treating cardiac arrhythmia
AT391316B (de) 1988-09-15 1990-09-25 Ebewe Arzneimittel Neue thienyloxy-alkylamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FR2665444B1 (fr) 1990-08-06 1992-11-27 Sanofi Sa Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant.
US5118707A (en) * 1990-10-31 1992-06-02 The Procter & Gamble Company Compositions for regulating skin wrinkles comprising a benzofuran derivative
EP0682524B1 (en) * 1993-02-02 2001-10-04 XOMA Technology Ltd. Pharmaceutical compositions containing bactericidal permeability increasing protein and a surfactant
US5364880A (en) 1993-06-16 1994-11-15 Advanced Therapies, Inc. Compound for treatment of cardiac arrhythmia, synthesis, and methods of use
US5447936A (en) * 1993-12-22 1995-09-05 Bionumerik Pharmaceuticals, Inc. Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof
KR0146671B1 (ko) * 1994-02-25 1998-08-17 김충환 사이클로스포린-함유 분말 조성물
FR2722984B1 (fr) * 1994-07-26 1996-10-18 Effik Lab Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
US5523309A (en) * 1995-03-10 1996-06-04 Eli Lilly And Company Benzofuran pharmaceutical compounds
FR2735365B1 (fr) * 1995-06-14 1997-09-05 Sanofi Sa Utilisation d'un antagoniste de l'angiotensine ii et d'un derive du benzofurane pour la preparation d'un medicament utile dans le traitement des affections cardiovasculaires
FR2735978B1 (fr) * 1995-06-30 1997-09-19 Sanofi Sa Composition pharmaceutique d'amiodarone pour administration parenterale
FR2740686B1 (fr) * 1995-11-03 1998-01-16 Sanofi Sa Formulation pharmaceutique lyophilisee stable
FR2746013B1 (fr) * 1996-03-18 1998-05-29 Sanofi Sa Utilisation de composes antiarythmiques dans la prevention de la mortalite post infarctus
SE9601421D0 (sv) * 1996-04-12 1996-04-12 Astra Ab New composition
FR2764800B1 (fr) * 1997-06-23 1999-09-10 Sanofi Sa Composition pharmaceutique solide contenant des derives de benzofuranne

Also Published As

Publication number Publication date
AU728287B2 (en) 2001-01-04
CN1267217A (zh) 2000-09-20
HUP0100412A3 (en) 2002-04-29
CZ295191B6 (cs) 2005-06-15
CY2010002I2 (el) 2010-07-28
DE69823360T3 (de) 2018-12-27
CA2294812A1 (fr) 1998-12-30
HUP0100412A2 (hu) 2001-12-28
JP2002506442A (ja) 2002-02-26
PL337870A1 (en) 2000-09-11
EE03852B1 (et) 2002-10-15
ZA985456B (en) 1999-12-23
FR2764800A1 (fr) 1998-12-24
KR100542089B1 (ko) 2006-01-12
IS5317A (is) 1999-12-21
HU229266B1 (en) 2013-10-28
SI1007030T1 (en) 2004-12-31
NO2010009I1 (no) 2010-05-06
EP1007030A1 (fr) 2000-06-14
US20160338989A1 (en) 2016-11-24
SK284972B6 (sk) 2006-03-02
US8318800B2 (en) 2012-11-27
NZ502464A (en) 2001-05-25
UY25062A1 (es) 2001-01-31
CO5011091A1 (es) 2001-02-28
EG23762A (en) 2007-08-08
IL133605A0 (en) 2001-04-30
EP1007030B1 (fr) 2004-04-21
AU8220398A (en) 1999-01-04
WO1998058643A1 (fr) 1998-12-30
DK1007030T3 (da) 2004-08-09
CA2294812C (fr) 2009-09-29
BR9810320A (pt) 2000-09-05
US20130116316A1 (en) 2013-05-09
NO2010009I2 (no) 2012-08-27
UA56243C2 (uk) 2003-05-15
DE69823360T2 (de) 2005-03-24
SK184699A3 (en) 2000-06-12
PT1007030E (pt) 2004-08-31
KR20010014098A (ko) 2001-02-26
TW548108B (en) 2003-08-21
FR10C0031I2 (no) 2011-04-29
US7323493B1 (en) 2008-01-29
ES2221178T7 (es) 2018-11-13
AR013117A1 (es) 2000-12-13
GT199800101A (es) 2000-01-04
ID23872A (id) 2000-05-25
US20080139645A1 (en) 2008-06-12
DZ2526A1 (fr) 2004-06-20
LU91673I2 (fr) 2010-06-07
CY2010002I1 (el) 2010-07-28
SA98190327B1 (ar) 2006-10-03
CN1091593C (zh) 2002-10-02
ATE264677T1 (de) 2004-05-15
NO326758B1 (no) 2009-02-09
PL190127B1 (pl) 2005-11-30
ES2221178T3 (es) 2004-12-16
FR10C0031I1 (no) 2010-06-11
US20170319538A1 (en) 2017-11-09
FR2764800B1 (fr) 1999-09-10
IS2340B (is) 2008-02-15
DE122010000029I1 (de) 2010-08-12
JP4577732B2 (ja) 2010-11-10
EE9900599A (et) 2000-08-15
HK1028352A1 (en) 2001-02-16
EP1007030B3 (fr) 2018-07-04
HRP980355A2 (en) 1999-02-28
MY122124A (en) 2006-03-31
NO996372L (no) 2000-02-23
RU2191578C2 (ru) 2002-10-27
DE69823360D1 (de) 2004-05-27
TR199903236T2 (xx) 2000-06-21
DK1007030T6 (da) 2018-09-24
HRP980355B1 (en) 2001-12-31
CZ466699A3 (cs) 2000-04-12

Similar Documents

Publication Publication Date Title
NO996372D0 (no) Fast farmasoeytisk preparat inneholdende benzofuanderivater
NO973612L (no) Nytt farmasöytisk preparat
NO20001160L (no) Nytt skumdannende farmasøytisk preparat
ID24654A (id) Formulasi farmasi omeprazola
NO20001612D0 (no) Oralt preparat
NO992339L (no) Farmasöytiske formuleringer
NO20005399D0 (no) Farmasøytisk preparat
MA26673A1 (fr) Composes pharmaceutiques
DK1466615T3 (da) Farmaceutisk præparat
NO20015149D0 (no) Nytt farmasöytisk preparat
NO20015148L (no) Nytt farmasöytisk preparat
NO995039L (no) Gastrisk bibeholdt farmasoeytisk preparat
NO973610D0 (no) Nytt farmasöytisk preparat
ID29294A (id) Komposisi farmasi
ID30032A (id) Formulasi farmasi
EE9900206A (et) N-sulfonüülindoliiniderivaate sisaldavad farmatseutilised kompositsioonid
ID25857A (id) Komposisi farmasi
NO20015104D0 (no) Nytt farmasöytisk preparat
NO973611D0 (no) Nytt farmasöytisk preparat
FI951155A (fi) Farmaseuttinen valmiste
NO20015105D0 (no) Nytt farmasöytisk preparat
NO20021036D0 (no) Farmasöytisk preparat
ID23531A (id) Komposisi farmasi
NO20003284L (no) Farmasøytisk preparat for oral administrering
FI3862U1 (fi) Geelimuotoinen farmaseuttinen valmiste

Legal Events

Date Code Title Description
SPCF Filing of supplementary protection certificate

Free format text: PRODUCT NAME: DRONEDARON (RINN) ER PRODUKTET AV STOFFET MULTAQ SOM OMFATTES I A. AV BASISPATENTETS KRAV 1, EKSPLISITT KRAV 2 OG HYDROKLORID (HCI) SALT I KRAV 4. SE OGSA THE MERCK INDEX; NAT. REG. NO/DATE: EU/1/09/591/001/NO- 20091215; FIRST REG. NO/DATE: EU/1/09/591/001-004 20091126

Spc suppl protection certif: 2010009

Filing date: 20100506

SPCG Granted supplementary protection certificate

Free format text: PRODUCT NAME: DRONEDARON (RINN) ER PRODUKTET AV STOFFET MULTAQ SOM OMFATTES I A. AV BASISPATENTETS KRAV 1, EKSPLISITT KRAV 2 OG HYDROKLORID (HCI) SALT I KRAV 4. SE OGSA THE MERCK INDEX; NAT. REG. NO/DATE: EU/1/09/591/001/NO- 20091215; FIRST REG. NO/DATE: EU/1/09/591/001-004 20091126

Spc suppl protection certif: 2010009

Filing date: 20100506

Extension date: 20230619

MK1K Patent expired
SPCS Change of name or address of the owner of a supplementary protection certificate

Owner name: SANOFI, FR

Spc suppl protection certif: 2010009

SPCX Expiry of an spc

Spc suppl protection certif: 2010009

Effective date: 20230705